NewAmsterdam Pharma Company
NAMS
#4447
Rank
โ‚ฌ1.75 B
Marketcap
19,02ย โ‚ฌ
Share price
-15.50%
Change (1 day)
119.12%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ57.33 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are โ‚ฌ57.33 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2021 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ48.43 M328.14%
2021-12-31โ‚ฌ11.31 M-28.19%
2020-12-31โ‚ฌ15.75 M